av Eirik A. Torheim | nov 24, 2023
A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumors Background Glioblastoma is an aggressive brain cancer and one example of deep-lying tumors that are difficult to access and treat with current...
av Aina Rengmark | des 9, 2020
Business opportunity Resistant hypertension (RHT) is a frequent disease and causes premature morbidity and death. RHT is defined as high blood pressure that remains above goal despite the use of three antihypertensive drugs of different classes. The prevalence of...
av Janncike Kristoffersen | aug 5, 2020
Business opportunity Scientists at Oslo University Hospital have developed a potent and specific inhibitor of tankyrase (OM-153), a master regulator of both WNT and YAP signaling pathways. These pathways are involved in the establishment and maintenance of cancer; at...
